Venture Capital

An Arizona summit connects builders with new talent, using tech and mental health initiatives to solve the industry's critical workforce shortage.

A strategic partnership with 5 Horizons Ventures accelerates Marvel Biosciences' novel drug, MB-204, into human trials for autism, Rett syndrome, and more.

FDA approves a pivotal trial for a novel heart valve, potentially revolutionizing treatment for millions with severe tricuspid regurgitation.

Harvard Business Review's 2025 prize signals a new era for leadership, rewarding a practical framework that moves beyond AI hype to strategic implementation.

The iconic wagon maker launches a powerful, compact eBike to make family transportation easier, safer, and more joyful. Is this the car-killer for cities?

Game co-dev leader Arrival hires a trio of Sony PlayStation veterans to lead a major expansion into Canada, signaling a new era for immersive game audio and narrative.

The e-commerce solutions giant appoints a new CPO from Realtor.com and Google to unify its platform and accelerate its ambitious AI-driven growth strategy.

The famed Shark Tank lobster roll brand is bringing its food truck to Madison, building on a successful Milwaukee launch and a growing Midwest appetite.

New research shows women executives are not just adopting AI, but are leading a charge for a more sustainable, human-centric approach to technology.

Millions of Californians are now covered by a new precision alert system as Genasys expands, signaling a major shift in public safety technology.

The AI leasing platform's SOC 2 Type II compliance removes a critical barrier, building the trust needed for widespread adoption in the multifamily sector.

A new bispecific antibody aims to treat the 50% of AxSpA patients who find no relief, as Fortitude Biomedicines enters a competitive autoimmune market.

With 150,000 subscribers, plant-powered odor eliminator Azuna enters Fresh Thyme Market, signaling a major shift for DTC brands in the booming natural CPG space.

Bedrock Ocean Exploration appoints Matthew Tirman as CEO, leveraging his space-tech background to scale autonomous ocean mapping in a booming market.

With new funding led by Telegraph Hill Partners, Kytopen is scaling its Flowfect® tech to make advanced cell therapies faster, cheaper, and more accessible.

With $7M from NEA and Madrona, Tableau's ex-CPO Francois Ajenstat debuts Golden Analytics, an AI-native platform designed to revolutionize data analysis.

Language services leader GLOBO hires a new CTO with deep AI expertise, signaling a major push to revolutionize communication for underserved populations.

Life Sciences Ontario's new board appointments signal a strategic shift, bringing in leaders from medtech, agri-tech, pharma, and nuclear isotopes.

In a major strategic move, Premier Research appoints Paul Spreen as CCO, signaling a bold push to capture the rebounding biotech market.

Rocket's new platform integrates AI strategy, app building, and market intelligence to solve what to build and how to compete after launch.